Search Results
Sep 09, 2026, 09:48 ET CSR SHAREHOLDER ALERT: Ademi LLP Investigates Whether Buyout Fairly Values Centerspace
Centerspace shareholders will receive only 3.800 shares of IRT common stock for each Centerspace share held, with Centerspace shareholders holding just 22% of the combined company; Ademi LLP is investigating the deal price, benefits to company insiders, and restrictions on competing offersCLICK
More news about: Ademi LLP
Sep 09, 2026, 09:00 ET Independence Realty Trust and Centerspace to Merge in $8.1 Billion Combination
transaction, IRT will file with the SEC a registration statement on Form S-4 that will include a joint proxy statement of Centerspace and IRT and a prospectus of IRT, as well as other relevant documents concerning the proposed transaction. The proposed transaction involving Centerspace and IRT will be submitted
More news about: Centerspace
Aug 28, 2026, 04:00 ET Leo Cancer Care Announces Commercial Collaboration with Leading Healthcare Solutions Provider to Bring Connected Imaging and Radiation Therapy Workflows to Market
and uneven access to advanced technology.The companies plan to explore how GE HealthCare's iRT software capabilities could connect with Leo Cancer Care's future upright radiation therapy solution. iRT is GE HealthCare's AI-supported software solution for radiation therapy that connects information,
More news about: Leo Cancer Care
Aug 18, 2026, 08:08 ET Sitero Extends Ash, a Clinical AI Agent, Across the Full Clinical Data Lifecycle
intelligence engine purpose-built for GxP environments. SiteroAI continuously ingests and harmonizes data from across the clinical ecosystem, including EDC, IRT/RTSM, central and local labs, ePRO, safety databases, and third-party vendor feeds, into a single, governed data layer. Ash operates directly on SiteroAI,
More news about: Sitero, LLC
May 26, 2026, 09:33 ET Lupus Research Alliance and Genentech Fund Researchers Translating CAR T Success into Durable Lupus Treatments
member of the Roche Group, announced the inaugural recipients of the Lupus Research Alliance-Genentech Award on Immune Resetting Therapies for Lupus (LGA-IRT). The new program aims to deepen our understanding of engineered cell therapies, an emerging approach that reprograms and resets the immune system,
More news about: Lupus Research Alliance
May 20, 2026, 08:30 ET Reduce Clinical Trial Site Burden Through Better Workflows and Fewer Delays, Upcoming Webinar Hosted by Xtalks
and how to create the most value for stakeholders across the clinical trial lifecycle. The featured speakers will discuss how a unified approach to IRT, eCOA and patient payments can ease the administrative workload and operational risk.TORONTO, May
More news about: Xtalks
May 05, 2026, 08:00 ET Atreo Marks 100th Study Launch, Accelerating the Shift to Next-Generation RTSM
the successful launch of its 100th study. Reaching this milestone reflects growing market demand for a more agile and scalable alternative to legacy IRT systems.
More news about: Atreo, Inc.
Apr 28, 2026, 08:30 ET Using AI to Responsibly Accelerate Clinical Trials Under Regulatory Scrutiny, Upcoming Webinar Hosted by Xtalks
Suvoda; Jadon Sargent, Senior Product Owner For Suvoda IRT and Sofia; and Andrew McVeigh, Chief Architect, Suvoda, for the live webinar on Wednesday, May 20, 2026, at 11am EDT (5pm CEST/EU-Central).For
More news about: Xtalks
Apr 27, 2026, 05:00 ET Perceptive eClinical Launches Technology-Enabled Clinical Supply Consultancy in Alliance with Trialzen
Belgium, April 27, 2026 /PRNewswire/ -- Perceptive eClinical, a leading provider of interactive response technology (IRT) and eClinical solutions, and Trialzen, an expert-led Forecasting and Supply Technology company, today announced an alliance supporting Perceptive eClinical
More news about: Perceptive eClinical Ltd
Apr 27, 2026, 05:00 ET Perceptive eClinical Launches Technology-Enabled Clinical Supply Consultancy in Alliance with Trialzen
Belgium, April 27, 2026 /PRNewswire/ -- Perceptive eClinical, a leading provider of interactive response technology (IRT) and eClinical solutions, and Trialzen, an expert-led Forecasting and Supply Technology company, today announced an alliance supporting Perceptive eClinical
More news about: Perceptive eClinical Ltd
Apr 21, 2026, 10:00 ET Arcwood Environmental Releases 2025 Sustainability Report Highlighting a Year of Transformation and Progress
deliver environmental solutions that create value for customers and communities. A key driver of this progress has been three strategic additions (MXI, IRT, and ERG) that expanded Arcwood's footprint and strengthened technical capabilities across key regions. These investments position Arcwood to manage
More news about: Arcwood Environmental
Apr 21, 2026, 09:45 ET Suvoda announces agentic RTSM, enabling the reduction of clinical trial startup timelines by up to 80%
The next evolution of Suvoda IRT is designed to accelerate study builds and change orders, elevate user experience, and deliver intelligent insightsCONSHOHOCKEN, Pa., April 21, 2026 /PRNewswire/ -- Getting
More news about: Suvoda LLC
Apr 21, 2026, 09:45 ET Suvoda introduces agentic RTSM, cutting clinical trial start-up timelines by up to 80%
Today, Suvoda, a global clinical trial technology company and a recognized leader in the RTSM space, announced agentic RTSM: the next evolution of Suvoda IRT that uses agentic AI to take a study from project kickoff to User Acceptance Testing (UAT) in as little as two weeks.Agentic RTSM is part of a
More news about: Suvoda LLC
Apr 21, 2026, 09:45 ET Suvoda führt das agentenbasierte RTSM ein und verkürzt die Vorbereitungszeit für klinische Studien um bis zu 80 %
Technologieunternehmen für klinische Studien und anerkannter Marktführer im Bereich RTSM, agentenbasiertes RTSM vorgestellt: die nächste Evolutionsstufe von Suvoda IRT, die mithilfe von agentenbasierter KI eine Studie in nur zwei Wochen vom Projektstart bis zur Benutzerabnahmeprüfung (UAT) begleitet.Agentenbasiertes
More news about: Suvoda LLC
Apr 21, 2026, 09:45 ET Suvoda presenta Agentic RTSM, reduciendo los plazos de inicio de los ensayos clínicos hasta en un 80 %
líder reconocido en el ámbito de la monitorización de ensayos clínicos en tiempo real (RTSM), anunció Agentic RTSM: la siguiente evolución de Suvoda IRT que utiliza IA con capacidad de gestión para llevar un estudio desde su inicio hasta las pruebas de aceptación del usuario (UAT) en tan solo dos semanas.Agentic
More news about: Suvoda LLC
Apr 21, 2026, 09:45 ET Suvoda introduit la RTSM agentique et réduite les délais de démarrage des essais cliniques jusqu'à 80 %.
la RTSM (Gestion de la randomisation et de l'approvisionnement des essais cliniques), a introduit la RTSM agentique : la nouvelle solution de Suvoda IRT qui utilise l'IA agentique pour faire passe une étude du lancement du projet au test d'acceptation utilisateur (TAU) en seulement deux semaines.La
More news about: Suvoda LLC
Jan 12, 2026, 10:00 ET Suvoda sets new standard for streamlined patient and site experience in clinical trials
clinical trialsSuvoda also simplified how study teams access critical information with Sofia, an AI assistant currently deployed in Suvoda IRT with platform expansion in the future. Sofia helps users ask questions and get answers with a generative AI tool, replacing multi-step navigation with
More news about: Suvoda LLC
Jan 12, 2026, 10:00 ET Suvoda sets new standard for streamlined patient and site experience in clinical trials
clinical trialsSuvoda also simplified how study teams access critical information with Sofia, an AI assistant currently deployed in Suvoda IRT with platform expansion in the future. Sofia helps users ask questions and get answers with a generative AI tool, replacing multi-step navigation with
More news about: Suvoda LLC
Jan 12, 2026, 10:00 ET Suvoda setzt neue Maßstäbe für eine optimierte Patienten- und Prüfzentrumserfahrung in klinischen Studien
administrativen Aufwand in klinischen Studien zu reduzierenSuvoda vereinfacht zudem mit Sofia, einer KI-Assistentin, die derzeit in Suvoda IRT eingesetzt wird und künftig auf weitere Teile der Plattform ausgeweitet werden soll, den Zugriff von Studienteams auf wichtige Informationen. Sofia hilft
More news about: Suvoda LLC
Jan 12, 2026, 10:00 ET Suvoda fija un nuevo estándar para optimizar la experiencia del paciente y del centro en ensayos clínicos
clínicosSuvoda también simplificó el acceso de los equipos de estudio a información crítica con Sofia, un asistente de IA implementado actualmente en Suvoda IRT y cuya plataforma se ampliará próximamente. Sofia ayuda a los usuarios a formular preguntas y obtener respuestas con una herramienta de IA generativa,
More news about: Suvoda LLC
Jan 12, 2026, 10:00 ET Suvoda définit une nouvelle norme pour la simplification de l'expérience des patients et des sites en matière d'essais cliniques
également simplifié les méthodes d'accès aux informations critiques par les équipes d'étude grâce à Sofia, un assistant IA actuellement déployé dans Suvoda IRT avec une prochaine expansion de la plateforme. Sofia aide les utilisateurs à poser des questions et à obtenir des réponses grâce à un outil d'IA générative,
More news about: Suvoda LLC
Jan 07, 2026, 13:00 ET Arcwood Environmental Acquires MXI Environmental Services/ Dynamic Recycling
Innovative Recycling Technologies (IRT). About Arcwood Environmental: At Arcwood Environmental, we minimize the impact of waste to clear the way for a better future.
More news about: Arcwood Environmental
Dec 11, 2025, 11:00 ET Suvoda IRT named a Leader in Everest Group's RTSM PEAK Matrix®
This recognition reaffirms that Suvoda IRT delivers unparalleled capabilities and speed for randomization and supply management in complex clinical trials," said Jagath Wanninayake, CEO of Suvoda. "It also reflects how we continue to advance our platform, bringing IRT together with our broader suite of products
More news about: Suvoda LLC
Dec 11, 2025, 11:00 ET Suvoda IRT named a Leader in Everest Group's RTSM PEAK Matrix®
This recognition reaffirms that Suvoda IRT delivers unparalleled capabilities and speed for randomization and supply management in complex clinical trials," said Jagath Wanninayake, CEO of Suvoda. "It also reflects how we continue to advance our platform, bringing IRT together with our broader suite of products
More news about: Suvoda LLC
Dec 11, 2025, 11:00 ET Suvoda IRT wird in der RTSM PEAK Matrix® der Everest Group als Leader ausgezeichnet
Suvoda IRT unvergleichliche Fähigkeiten und Geschwindigkeit für die Randomisierung und das Versorgungsmanagement in komplexen klinischen Studien bietet", sagte Jagath Wanninayake, Geschäftsführer von Suvoda. „Es spiegelt auch wider, wie wir unsere Plattform weiterentwickeln, indem wir das IRT mit unserer
More news about: Suvoda LLC